Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1987 1
1990 1
1991 7
1992 3
1993 6
1994 3
1995 8
1996 5
1997 7
1998 7
1999 7
2000 10
2001 14
2002 18
2003 13
2004 16
2005 21
2006 29
2007 18
2008 23
2009 20
2010 30
2011 45
2012 64
2013 54
2014 70
2015 60
2016 64
2017 41
2018 41
2019 30
2020 37
2021 68
2022 62
2023 64
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

866 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I. André F, et al. Among authors: aksoy s. Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086745 Clinical Trial.
Microbiota in disease-transmitting vectors.
Wang J, Gao L, Aksoy S. Wang J, et al. Among authors: aksoy s. Nat Rev Microbiol. 2023 Sep;21(9):604-618. doi: 10.1038/s41579-023-00901-6. Epub 2023 May 22. Nat Rev Microbiol. 2023. PMID: 37217793 Review.
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, Dogan HT, Dogan M, Jandaghi P, Isik A, Gundogdu F, Kosemehmetoglu K, Dizdar O, Aksoy S, Akyol A, Uner A, Buckhaults PJ, Riazalhosseini Y, Sahin O. Saatci O, et al. Among authors: aksoy s. Nat Commun. 2020 May 15;11(1):2416. doi: 10.1038/s41467-020-16199-4. Nat Commun. 2020. PMID: 32415208 Free PMC article.
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Machiels JP, Tao Y, Burtness B, Tahara M, Licitra L, Rischin D, Waldron J, Simon C, Gregoire V, Harrington K, Alves GV, Figueiredo Lima IP, Pointreau Y, M Hughes BG, Aksoy S, Hetnal M, Ge JY, Brown H, Cheng J, Bidadi B, Siu LL. Machiels JP, et al. Among authors: aksoy s. Future Oncol. 2020 Jun;16(18):1235-1243. doi: 10.2217/fon-2020-0184. Epub 2020 Jun 3. Future Oncol. 2020. PMID: 32490686 Free article.
World neglected tropical diseases day.
Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. Hotez PJ, et al. Among authors: aksoy s. PLoS Negl Trop Dis. 2020 Jan 29;14(1):e0007999. doi: 10.1371/journal.pntd.0007999. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31995572 Free PMC article.
What constitutes a neglected tropical disease?
Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. Hotez PJ, et al. Among authors: aksoy s. PLoS Negl Trop Dis. 2020 Jan 30;14(1):e0008001. doi: 10.1371/journal.pntd.0008001. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31999732 Free PMC article.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Nahit Sendur MA. Kahraman S, et al. Among authors: aksoy s. Future Oncol. 2023 Mar;19(10):727-736. doi: 10.2217/fon-2022-1287. Epub 2023 May 3. Future Oncol. 2023. PMID: 37133230
Cancer Prevalence Across Vertebrates.
Compton ZT, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Compton ZT, et al. Among authors: aksoy s. Res Sq [Preprint]. 2023 Jul 6:rs.3.rs-3117313. doi: 10.21203/rs.3.rs-3117313/v1. Res Sq. 2023. PMID: 37461608 Free PMC article. Preprint.
Cancer Prevalence Across Vertebrates.
Compton Z, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Compton Z, et al. Among authors: aksoy s. bioRxiv [Preprint]. 2023 Feb 16:2023.02.15.527881. doi: 10.1101/2023.02.15.527881. bioRxiv. 2023. PMID: 36824942 Free PMC article. Preprint.
866 results